Kalbitor
Active Ingredient(s): EcallantideFDA Approved: * November 27, 2009
Pharm Company: * DYAX CORP.
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Kalbitor Overview
Ecallantide (trade name Kalbitor) is a drug used for the treatment of hereditary angioedema (HAE) and in the prevention of blood loss in cardiothoracic surgery.[1] It is an inhibitor of the protein kallikrein and a 60-amino acid polypeptide which was developed from a Kunitz domain through phage display to mimic antibodies inhibiting kallikrein.[1] Contents 1 Medical uses 1.1 Angioedema 2 Adverse effects 3 Interactions 4 Mechanism of action 5 See also 6 Ref...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ecallantide
Recent Kalbitor Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Ecallantide
- Injection: 10mg/ml
NDC Database Records for Kalbitor: (2 results)
Sorted by National Drug Code- 47783-101 Kalbitor 10 mg/ml Subcutaneous Injection, Solution by Dyax Corp.
- 65044-7611 Kalbitor 10 mg/ml Subcutaneous Injection, Solution by Jubilant Hollisterstier LLC